AKT1 and familial pancreatic carcinoma: Previous studies confirmed that chidamide suppresses the PI3K/Akt and MAPK/Ras signaling pathways, arresting pancreatic cancer cells at the G1 phase of the cell cycle and promoting apoptosis[19].